Clinical Trial Update: An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps [Phase 3]

View source ↗

Summary

An extension Phase 3 trial to assess the long-term safety and tolerability of itepekimab in adults with inadequately controlled chronic rhinosinusitis with nasa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• itepekimab (itepekimab)

Snippet

Sponsor: Sanofi | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 3 | Status: ENROLLING_BY_INVITATION